SMS Lifesciences India Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
SMS Lifesciences India heeft een totaal eigen vermogen van ₹2.0B en een totale schuld van ₹894.9M, wat de schuld-eigenvermogensverhouding op 44% brengt. De totale activa en totale passiva bedragen respectievelijk ₹3.9B en ₹1.9B. De EBIT SMS Lifesciences India is ₹307.4M waardoor de rentedekking 3.3 is. Het heeft contanten en kortetermijnbeleggingen van ₹11.9M.
Belangrijke informatie
44.0%
Verhouding schuld/eigen vermogen
₹894.94m
Schuld
Rente dekkingsratio | 3.3x |
Contant | ₹11.92m |
Aandelen | ₹2.03b |
Totaal verplichtingen | ₹1.88b |
Totaal activa | ₹3.91b |
Recente financiële gezondheidsupdates
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹1.5B ) SMSLIFE } overtreffen de korte termijn passiva ( ₹1.4B ).
Langlopende schulden: De kortetermijnactiva SMSLIFE ( ₹1.5B ) overtreffen de langetermijnschulden ( ₹441.0M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 43.4% ) SMSLIFE wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van SMSLIFE is de afgelopen 5 jaar gestegen van 42% naar 44%.
Schuldendekking: De schuld van SMSLIFE wordt goed gedekt door de operationele kasstroom ( 37.4% ).
Rentedekking: De rentebetalingen op de schuld van SMSLIFE worden goed gedekt door EBIT ( 3.3 x dekking).